125 related articles for article (PubMed ID: 8957636)
41. Case report 799: Extraskeletal chondrosarcoma (Fig. 3).
Sundaram M; Percelay S; McDonald DJ; Janney C
Skeletal Radiol; 1993 Aug; 22(6):449-51. PubMed ID: 8248821
[TBL] [Abstract][Full Text] [Related]
42. In-111 octreotide scan in a case of a neuroendocrine tumor of unknown origin.
Fuster D; Navasa M; Pons F; Vidal-Sicart S; Mateos JJ; Lomeña F; Rodes J; Herranz R
Clin Nucl Med; 1999 Dec; 24(12):955-8. PubMed ID: 10595476
[TBL] [Abstract][Full Text] [Related]
43. Neuroendocrine carcinomas of the lung and role of 111In-DTPA-octreotide scintigraphy: preliminary results.
Oliaro A; Filosso PL; Bello M; Casadio C; Muni A; Greco B; Bertuccio G; Bisi G; Maggi G
J Cardiovasc Surg (Torino); 1996 Dec; 37(6):653-6. PubMed ID: 9016988
[TBL] [Abstract][Full Text] [Related]
44. 111In-octreotide scintigraphy in pituitary adenomas.
Tofani A; Cucchi R; Pompili A; Carapella C; Crecco M; Mottolese M; Maini CL
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):94-7. PubMed ID: 9002760
[TBL] [Abstract][Full Text] [Related]
45. Mesenchymal chondrosarcoma of bone and soft tissues.
Bertoni F; Picci P; Bacchini P; Capanna R; Innao V; Bacci G; Campanacci M
Cancer; 1983 Aug; 52(3):533-41. PubMed ID: 6861090
[TBL] [Abstract][Full Text] [Related]
46. 111In-octreotide scintigraphy in small cell lung cancer.
Semprebene A; Ferraironi A; Franciotti G; Venturo I; Giunta S; Lopez M; Maini CL
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):108-10. PubMed ID: 9002764
[TBL] [Abstract][Full Text] [Related]
47. Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings.
De Jong M; Valkema R; Jamar F; Kvols LK; Kwekkeboom DJ; Breeman WA; Bakker WH; Smith C; Pauwels S; Krenning EP
Semin Nucl Med; 2002 Apr; 32(2):133-40. PubMed ID: 11965608
[TBL] [Abstract][Full Text] [Related]
48. Indium-111-DTPA-D-Phe-1-octreotide and technetium-99m-(V)-dimercaptosuccinic acid scanning in the preoperative staging of medullary thyroid carcinoma.
Kurtaran A; Scheuba C; Kaserer K; Schima W; Czerny C; Angelberger P; Niederle B; Virgolini I
J Nucl Med; 1998 Nov; 39(11):1907-9. PubMed ID: 9829581
[TBL] [Abstract][Full Text] [Related]
49. Adult medulloblastoma relapse visualized by in-111 octreotide scintigraphy.
Infante JR; Rayo JI; Serrano J; Domínguez ML; García L; Sánchez R
Clin Nucl Med; 2006 Oct; 31(10):633-5. PubMed ID: 16985373
[No Abstract] [Full Text] [Related]
50. Detection of extrathoracic manifestations in sarcoidosis with somatostatin analogue scintigraphy.
Eklund A; Jacobsson H; Larsson SA; Sköld CM
Sarcoidosis Vasc Diffuse Lung Dis; 1997 Sep; 14(2):146-51. PubMed ID: 9306505
[TBL] [Abstract][Full Text] [Related]
51. Somatostatin and the concept of peptide receptor scintigraphy in oncology.
Lamberts SW; Reubi JC; Krenning EP
Semin Oncol; 1994 Oct; 21(5 Suppl 13):1-5. PubMed ID: 7992074
[No Abstract] [Full Text] [Related]
52. Effect of chemotherapy on somatostatin receptor detection with octreotide scintigraphy in hormone-refractory prostate cancer patients.
Mencobonii M; Tredici S; Rebella L; Bergaglio M; Galbusera V; Manzara A; Claudiani F; Malcangi B; Varaldo M
Anticancer Res; 2006; 26(3B):2233-5. PubMed ID: 16821593
[TBL] [Abstract][Full Text] [Related]
53. [Nuclear oncology with monoclonal antibodies and peptides].
Hosono M
Kaku Igaku; 1998 Oct; 35(8):681-7. PubMed ID: 9847509
[TBL] [Abstract][Full Text] [Related]
54. Ga-67 and In-111 pentreotide imaging.
Spieth ME; Vasinrapee P
Clin Nucl Med; 1996 Jan; 21(1):80. PubMed ID: 8741905
[No Abstract] [Full Text] [Related]
55. [Preliminary results on the use of scintigraphy with radiolabelled octreotide as diagnostic method in neuroendocrine and nonendocrine neoplasms of the lung].
Oliaro A; Filosso PL; Bellò M; Casadio C; Muni A; Angusti T; Masaneo I; Bisi G; Maggi G
Minerva Chir; 1997 Nov; 52(11):1335-8. PubMed ID: 9489331
[TBL] [Abstract][Full Text] [Related]
56. Somatostatin receptor scintigraphy (SRS): a new diagnostic tool in neuroblastoma (NB)?
Dörr U; Sautter-Bihl ML; Schilling FH; Koscielniak E; Treuner J; Bihl H
Prog Clin Biol Res; 1994; 385():355-61. PubMed ID: 7972231
[No Abstract] [Full Text] [Related]
57. [Radiologic diagnosis of malignant tumors of the pelvic bones in children].
Durnov LA; Koshechkina NA; Kolesnik EV; Kaminskaia IV; Ivanova NM; Boĭchenko EI; Rezun SI
Vopr Onkol; 2000; 46(4):410-4. PubMed ID: 11147414
[TBL] [Abstract][Full Text] [Related]
58. [A case of metastatic gastrinomas in the liver visualized by 111In-DTPA-D-Phe-octreotide (111In-pentetreotide)].
Tani A; Nakabeppu Y; Tsuchimochi S; Nakajo M; Yoshinaga T; Kiku T
Kaku Igaku; 1996 May; 33(5):545-9. PubMed ID: 8699623
[TBL] [Abstract][Full Text] [Related]
59. The appearance of malignant fibrous histiocytoma on a three-phase bone scan.
Stemerman DH
Clin Nucl Med; 1996 May; 21(5):398-9. PubMed ID: 8732839
[No Abstract] [Full Text] [Related]
60. 111Indium-diethylenetriamine pentaacetic acid CSF flow studies predict distribution of intrathecally administered chemotherapy and outcome in patients with leptomeningeal metastases.
Chamberlain MC; Kormanik P; Jaeckle KA; Glantz M
Neurology; 1999 Jan; 52(1):216-7. PubMed ID: 9921888
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
